Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8801-8810 of 12128

Page
per page
  1. IQ 3
    B9015 IQ 3
    Summary: Selective JNK3 inhibitor
      <6.83 mg/mL
  2. Indirubin
    B3672 Indirubin
    Target: Cyclin-Dependent Kinases|GSK-3
    Summary: cyclin-dependent kinases and GSK-3β inhibitor
      insoluble in H2O; insoluble in H2O; insoluble in EtOH; ≥13.1 mg/mL
  3. NMS-1286937
    B4094 NMS-1286937
    Target: PLK
    Summary: PLK1 inhibitor, orally bioavailable
      insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL
  4. Losmapimod
    B4620 Losmapimod
     4 Citation
    Summary: p38 MAPK inhibitor, orally active
      insoluble in EtOH; insoluble in H2O; ≥19.15 mg/mL
  5. Vidofludimus
    B4669 Vidofludimus
    Summary: DHODH inhibitor
      insoluble in H2O; insoluble in EtOH; ≥103 mg/mL
  6. PACOCF3
    B6747 PACOCF3
    Summary: CPLA2 and iPLA2 inhibitor
      Soluble in DMSO
  7. (±)-HIP-A
    B6982 (±)-HIP-A
    Summary: excitatory amino acid transporter (EAAT) blocker
      insoluble in H2O
  8. PD 176252
    B7122 PD 176252
    Summary: gastrin-releasing peptide receptor (GRP-R, BB2) and neuromedin B receptor (NMB-R, BB1) antagonist
      <58.47 mg/mL
  9. Withaferin A
    B7199 Withaferin A
     2 Citation
    Summary: Prevents NF-κB activation by inhibiting activation of IKKβ
      Soluble in DMSO
  10. Sulprostone
    B7255 Sulprostone
    Summary: EP3 and EP1 receptor agonist

Items 8801-8810 of 12128

Page
per page